This doctoral-level course develops advanced clinical competency in dietary supplement science for two specialized, high-stakes populations: oncology clients and women across the hormonal lifespan. Oncology modules address supplement safety for the most common cancers encountered in integrative practice (breast, prostate, colorectal, and lung), with an emphasis on hepatic CYP450 metabolism, supplement-chemotherapy interactions, antioxidant considerations during active treatment, and mandatory oncology team consultation protocols. Women’s health modules cover PCOS, thyroid conditions, fertility, and the full perimenopause-to-post-menopause transition, drawing on clinical practice guidelines.
Construct and defend supplement safety protocols for oncology clients across specific phases of care (active treatment, post-treatment, and survivorship) to critically evaluate pharmacokinetic risks of supplement-chemotherapy and supplement-radiation interactions across all major cancer types and to justify clinical safety decisions.
Construct evidence-based supplement protocols for the most common cancer populations encountered in integrative practice (breast, prostate, colorectal, and lung) by critically synthesizing primary research literature to identify what is supported, what is contraindicated, and where evidence gaps require clinical caution.
Design individualized supplement protocols for women with reproductive and hormonal health conditions, including PCOS, thyroid dysfunction, and fertility concerns, incorporating biomarker-guided monitoring, population-specific safety considerations, and the interaction between supplementation and hormonal physiology.
Evaluate the evidence base for supplements for perimenopause, menopause, and post-menopausal aging, including bone density, cardiovascular risk, cognitive function, and hormonal symptom management, in order to translate evidence into clinically defensible, individualized recommendations that account for the complexity of the hormonal transition.
Integrate oncology and women’s health supplement knowledge to develop comprehensive clinical protocols for clients with hormone-sensitive and gynecologic cancers, demonstrating doctoral-level judgment in resolving the clinical tensions between oncology safety requirements and women’s health supplement needs.
Critically evaluate an unresolved evidence conflict at the intersection of oncology safety and women’s health supplement needs, and formulate a structured clinical or research question (using a PICO or SPIDER framework) that articulates its significance for future practice guidelines, case-based publication, or collaborative research in integrative oncology and women’s health.
Required Course Pack:
Required Textbooks:
View the required textbooks for this class, including ISBN, edition, and retail price, by visiting our Required Textbooks page.
Total Course Price:
View the total course price including tuition, fees, course materials, and shipping online here.
View all ACHS instructors, including bios, photos, and courses taught.
Candidates must possess a baccalaureate degree or higher from an institution accredited by an agency recognized by the US Department of Education. Candidates must submit official transcripts directly from the issuing institution along with one professional letter of recommendation. All applicants must be recommended for admission by the ACHS Admissions Committee.
View the total course price including tuition, fees, course materials, and shipping.
